Message Communicating Latest Data on COVID-19 Transmission in Patient's Area
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 520,000
- 试验地点
- 2
- 主要终点
- Patient uptake of COVID bivalent booster
研究概览
简要总结
This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination by communicating to patients that they live in an area with significant COVID transmission and a control message telling patients that an updated COVID booster vaccine is waiting for them.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- Double (Care Provider, Outcomes Assessor)
盲法说明
As treated participants will receive text messages, there is no scope for blinding. Care providers will not be made aware of subjects' participation in the study, or assigned treatment arms. The study team will only receive data on subjects' assigned arms and outcomes at the end of the study.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •The patient unsubscribed from texts before the send date and time of the patient's SMS/MMS message
- •The patient received a bivalent COVID booster before the send date and time of the patient's SMS/MMS message.
结局指标
主要结局
Patient uptake of COVID bivalent booster
时间窗: During the 30 days after receiving the SMS/MMS intervention
Whether patients receive a bivalent COVID booster at the pharmacy in question
次要结局
- Patient uptake of COVID bivalent booster(90 days after receiving the SMS/MMS intervention)